Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function by Belchamber KBR, Thomas CMR, Dunne AE, Barnes PJ, Donnelly LE

Get full text

Decreased phosphatase PTEN amplifies PI3K signaling and enhances proinflammatory cytokine release in COPD by Yanagisawa, S, Baker, JR, Vuppusetty, C, Fenwick, P, Donnelly, LE, Ito, K, Barnes, PJ

Decreased Serum Sirtuin-1 in COPD by Yanagisawa, S, Papaioannou, AI, Papaporfyriou, A, Baker, JR, Vuppusetty, C, Loukides, S, Barnes, PJ, Ito, K

MicroRNA-570 is a novel regulator of cellular senescence and inflammaging by Baker, JR, Vuppusetty, C, Colley, T, Hassibi, S, Fenwick, PS, Donnelly, LE, Ito, K, Barnes, PJ

The dynamic shuttling of SIRT1 between cytoplasm and nuclei in bronchial epithelial cells by single and repeated cigarette smoke exposure by Yanagisawa, S, Baker, JR, Vuppusetty, C, Koga, T, Colley, T, Fenwick, P, Donnelly, LE, Barnes, PJ, Ito, K

Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells by Baker, JR, Vuppusetty, C, Colley, T, Papaioannou, AI, Fenwick, P, Donnelly, L, Ito, K, Barnes, PJ

Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial by Bradbury T, Di Tanna GL, Scaria A, Martin A, Wen FQ, Zhong NS, Zheng JP, Barnes PJ, Celli B, Berend N, Jenkins CR

Get full text

Bronchial asthma and interleukin-5 by Das Undurti, Leckie MJ, Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ

Get full text

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019 by Singh, D, Agusti, A, Anzueto, A, Barnes, PJ, Bourbeau, J, Celli, BR, Criner, GJ, Frith, P, Halpin, DMG, Han, M, López Varela, MV, Martinez, F, Montes De Oca, M, Papi, A, Pavord, ID, Roche, N, Sin, DD, Stockley, R, Vestbo, J, Wedzicha, JA, Vogelmeier, C

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial by Yu, L-M, Bafadhel, M, Dorward, JJ, Hayward, G, Saville, BR, Gbinigie, O, Van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Richards, D, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Shanyinde, M, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Ramakrishnan, S, Hobbs, FDR, Butler, CC, Yu, L-M, Bafadhel, M, Dorward, J, Hayward, G, Saville, BR, Gbinigie, O, van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Richards, D, Berry, N, Detry, MA, Saunders, CT, Fitzgerald, M, Harris, V, Shanyinde, M, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Ramakrishnan, S

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial by Yu, L-M, Ramakrishnan, S, Bafadhel, M, Dorward, J, Hayward, G, Saville, BR, Gbinigie, O, van Hecke, O, Ogburn, E, Evans, PH, Thomas, NPB, Patel, MG, Berry, N, Detry, MA, Saunders, CT, Fitzgerald, M, Harris, V, de Lusignan, S, Andersson, MI, Barnes, PJ, Russell, REK, Nicolau, DV, Hobbs, FDR, Butler, CC

Current controversies in chronic obstructive pulmonary disease. A report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee by Criner, GJ, Martinez, FJ, Aaron, S, Agusti, A, Anzueto, A, Bafadhel, M, Barnes, PJ, Bourbeau, J, Chen, R, Ewig, J, Fabbri, LM, Frith, P, Halpin, DMG, Han, M, De Oca, M, Nishimura, M, O'Donnell, D, Papi, A, Pavord, I, Roche, N, Rodriguez-Roisin, R, Salvi, S, Singh, D, Sin, DD, Stockley, R, Varela, MV, Vestbo, J, Vogelmeier, CF, Washko, G, Wedzicha, JA, Celli, BR